Table 1.
Antibiotic surgical prophylaxis received | Antibiotic dosage | Patient study ID | Age (years) | Sex |
S. aureus nasal carriage detected by conventional culture on admission |
Surgical speciality | Surgical procedure | Sample days |
---|---|---|---|---|---|---|---|---|
No antibiotics | 25 | 79 | Female | No | Orthopaedic | None | 5 | |
99 | 52 | Male | Yes | Cardiology | Angioplasty | 4 | ||
101 | 83 | Female | No | Cardiology | Angioplasty | 4 | ||
105 | 63 | Male | Yes | Cardiology | Angioplasty | 5 | ||
111 | 68 | Female | Yes | Cardiology | Angioplasty | 5 | ||
113 | 79 | Female | No | Cardiology | Angioplasty | 3 | ||
Flucloxacillin (1 g) and gentamicin (160 mg) | Single dose IV on induction, and 2 further doses of flucloxacillin (1 g) post op at 6-h intervals | 34 | 87 | Female | No | Gamma Nail | 7 | |
36 | 87 | Female | No | Orthopaedic | Gamma Nail | 7 | ||
42 | 88 | Female | Yes | Orthopaedic | Dynamic Hip Screw | 7 | ||
51 | 82 | Female | No | Orthopaedic | Dynamic Hip Screw | 5 | ||
56 | 72 | Female | No | Orthopaedic | Open Reduction of internal fracture of wrist and K wires | 7 | ||
61 | 88 | Male | Yes | Orthopaedic | Total knee replacement | 5 | ||
Orthopaedic | ||||||||
Teicoplanin (400 mg) +/− gentamicin (160 mg) | Single dose IV on induction | 35b | 80 | Female | No | Orthopaedic | Hemiarthroplasty | 7 |
37b | 91 | Female | Yes | Orthopaedic | Hemiarthroplasty | 7 | ||
65a | 76 | Female | No | Orthopaedic | Total hip replacement | 4 | ||
86b | 71 | Male | Yes | Orthopaedic | Total hip replacement | 4 | ||
90a | 81 | Female | Yes | Orthopaedic | Hemiarthroplasty | 5 | ||
93a | 89 | Female | Yes | Orthopaedic | Hemiarthroplasty | 4 |
aTeicoplanin alone
bTeicoplanin and gentamicin